The FDA Approves Roche’s Antibody Drug Polivy to Treat Lymphoma Patients
In March the FDA’s expert advisers voted 11 to 2 in favor of approving Roche’s antibody drug Polivy to treat lymphoma patients. According to an article in BiopharmaDive, the decision…